Targeted screening for the detection of Pompe disease in patients with unclassified limb-girdle muscular dystrophy or asymptomatic hyperCKemia using dried blood: A Spanish cohort
- 23 April 2015
- journal article
- research article
- Published by Elsevier BV in Neuromuscular Disorders
- Vol. 25 (7), 548-553
- https://doi.org/10.1016/j.nmd.2015.04.008
Abstract
No abstract availableKeywords
Funding Information
- Genzyme Spain
This publication has 28 references indexed in Scilit:
- Screening for later-onset Pompe's disease in patients with paucisymptomatic hyperCKemiaMolecular Genetics and Metabolism, 2013
- Pompe disease: Design, methodology, and early findings from the Pompe RegistryMolecular Genetics and Metabolism, 2011
- EFNS guidelines on the diagnostic approach to pauci‐ or asymptomatic hyperCKemiaEuropean Journal of Neurology, 2010
- Diagnostic efficacy of the fluorometric determination of enzyme activity for Pompe disease from dried blood specimens compared with lymphocytes—possibility for newborn screeningJournal of Inherited Metabolic Disease, 2009
- Diagnostic criteria for late‐onset (childhood and adult) pompe diseaseMuscle & Nerve, 2009
- Screening for pompe disease using a rapid dried blood spot method: Experience of a clinical diagnostic laboratoryMuscle & Nerve, 2009
- Diagnosis of glycogenosis type IINeurology, 2008
- Late onset Pompe disease: Clinical and neurophysiological spectrum of 38 patients including long-term follow-up in 18 patientsNeuromuscular Disorders, 2007
- Pompe disease diagnosis and management guidelineGenetics in Medicine, 2006
- Computed tomography and magnetic resonance imaging of affected muscle in childhood acid α-glucosidase deficiency: a case reportBrain & Development, 1993